Anticoagulation Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL ANTICOAGULATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Anticoagulation Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Anticoagulation Market by Drug Class
3.3.1: Novel Oral Anticoagulants
3.3.2: Heparin and Low Molecular Weight Heparin
3.3.3: Vitamin K Antagonist
3.3.4: Others
3.4: Global Anticoagulation Market by Route of Administration
3.4.1: Oral
3.4.2: Injectable
3.5: Global Anticoagulation Market by Application
3.5.1: Atrial Fibrillation/Myocardial Infarction
3.5.2: Deep Vein Thrombosis
3.5.3: Pulmonary Embolism
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Anticoagulation Market by Region
4.2: North American Anticoagulation Market
4.2.2: North American Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.3: European Anticoagulation Market
4.3.1: European Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.3.2: European Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.4: APAC Anticoagulation Market
4.4.1: APAC Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.4.2: APAC Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.5: ROW Anticoagulation Market
4.5.1: ROW Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.5.2: ROW Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Anticoagulation Market by Drug Class
6.1.2: Growth Opportunities for the Global Anticoagulation Market by Route of Administration
6.1.3: Growth Opportunities for the Global Anticoagulation Market by Application
6.1.4: Growth Opportunities for the Global Anticoagulation Market by Region
6.2: Emerging Trends in the Global Anticoagulation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Anticoagulation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoagulation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Johnson & Johnson
7.2: Bayer
7.3: Boehringer Ingelheim
7.4: Bristol-Myers Squibb
7.5: Daiichi Sankyo
2. GLOBAL ANTICOAGULATION MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Anticoagulation Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Anticoagulation Market by Drug Class
3.3.1: Novel Oral Anticoagulants
3.3.2: Heparin and Low Molecular Weight Heparin
3.3.3: Vitamin K Antagonist
3.3.4: Others
3.4: Global Anticoagulation Market by Route of Administration
3.4.1: Oral
3.4.2: Injectable
3.5: Global Anticoagulation Market by Application
3.5.1: Atrial Fibrillation/Myocardial Infarction
3.5.2: Deep Vein Thrombosis
3.5.3: Pulmonary Embolism
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Anticoagulation Market by Region
4.2: North American Anticoagulation Market
4.2.2: North American Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.3: European Anticoagulation Market
4.3.1: European Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.3.2: European Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.4: APAC Anticoagulation Market
4.4.1: APAC Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.4.2: APAC Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
4.5: ROW Anticoagulation Market
4.5.1: ROW Anticoagulation Market by Drug Class: Novel Oral Anticoagulants , Heparin and Low Molecular Weight Heparin, Vitamin K Antagonist , and Others
4.5.2: ROW Anticoagulation Market by Application: Atrial Fibrillation/Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism , and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Anticoagulation Market by Drug Class
6.1.2: Growth Opportunities for the Global Anticoagulation Market by Route of Administration
6.1.3: Growth Opportunities for the Global Anticoagulation Market by Application
6.1.4: Growth Opportunities for the Global Anticoagulation Market by Region
6.2: Emerging Trends in the Global Anticoagulation Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Anticoagulation Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoagulation Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Johnson & Johnson
7.2: Bayer
7.3: Boehringer Ingelheim
7.4: Bristol-Myers Squibb
7.5: Daiichi Sankyo
